BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20226875)

  • 1. Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice.
    Toda K; Hayashi Y; Saibara T
    Biochim Biophys Acta; 2010 Jun; 1801(6):655-64. PubMed ID: 20226875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse.
    Chow JD; Jones ME; Prelle K; Simpson ER; Boon WC
    J Endocrinol; 2011 Sep; 210(3):323-34. PubMed ID: 21705395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice.
    Van Sinderen ML; Steinberg GR; Jørgensen SB; Honeyman J; Chow JD; Herridge KA; Winship AL; Dimitriadis E; Jones ME; Simpson ER; Boon WC
    PLoS One; 2015; 10(8):e0136143. PubMed ID: 26317527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse.
    Van Sinderen ML; Steinberg GR; Jørgensen SB; To SQ; Knower KC; Clyne CD; Honeyman J; Chow JD; Herridge KA; Jones ME; Simpson ER; Boon WC
    PLoS One; 2014; 9(2):e87230. PubMed ID: 24520329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse.
    Hewitt KN; Pratis K; Jones ME; Simpson ER
    Endocrinology; 2004 Apr; 145(4):1842-8. PubMed ID: 14684602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity.
    Jones ME; Thorburn AW; Britt KL; Hewitt KN; Wreford NG; Proietto J; Oz OK; Leury BJ; Robertson KM; Yao S; Simpson ER
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12735-40. PubMed ID: 11070087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency.
    Takeda K; Toda K; Saibara T; Nakagawa M; Saika K; Onishi T; Sugiura T; Shizuta Y
    J Endocrinol; 2003 Feb; 176(2):237-46. PubMed ID: 12553872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice.
    Scott NJ; Cameron VA; Raudsepp S; Lewis LK; Simpson ER; Richards AM; Ellmers LJ
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E576-84. PubMed ID: 22185842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain.
    Geis C; Graulich M; Wissmann A; Hagenacker T; Thomale J; Sommer C; Schäfers M
    Neuroscience; 2010 Aug; 169(1):463-74. PubMed ID: 20417692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dimorphism in the glucose homeostasis phenotype of the Aromatase Knockout (ArKO) mice.
    Van Sinderen M; Steinberg G; Jorgensen SB; Honeyman J; Chow JDY; Simpson ER; Jones MEE; Boon WC
    J Steroid Biochem Mol Biol; 2017 Jun; 170():39-48. PubMed ID: 27353462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal lipid/lipoprotein metabolism and high plasma testosterone levels in male but not female aromatase-knockout mice.
    Amano A; Kondo Y; Noda Y; Ohta M; Kawanishi N; Machida S; Mitsuhashi K; Senmaru T; Fukui M; Takaoka O; Mori T; Kitawaki J; Ono M; Saibara T; Obayashi H; Ishigami A
    Arch Biochem Biophys; 2017 May; 622():47-58. PubMed ID: 28341248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice.
    Nemoto Y; Toda K; Ono M; Fujikawa-Adachi K; Saibara T; Onishi S; Enzan H; Okada T; Shizuta Y
    J Clin Invest; 2000 Jun; 105(12):1819-25. PubMed ID: 10862797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue.
    Jones ME; Thorburn AW; Britt KL; Hewitt KN; Misso ML; Wreford NG; Proietto J; Oz OK; Leury BJ; Robertson KM; Yao S; Simpson ER
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):3-9. PubMed ID: 11850201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17beta-estradiol or a peroxisome proliferator.
    Toda K; Takeda K; Akira S; Saibara T; Okada T; Onishi S; Shizuta Y
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):11-7. PubMed ID: 11850202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria.
    Moro L; Arbini AA; Hsieh JT; Ford J; Simpson ER; Hajibeigi A; Oz OK
    Endocrinology; 2010 Apr; 151(4):1643-52. PubMed ID: 20194728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aromatase or estrogen receptor gene deletion on masculinization of the principal nucleus of the bed nucleus of the stria terminalis of mice.
    Tsukahara S; Tsuda MC; Kurihara R; Kato Y; Kuroda Y; Nakata M; Xiao K; Nagata K; Toda K; Ogawa S
    Neuroendocrinology; 2011; 94(2):137-47. PubMed ID: 21525731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse.
    Ling S; Dai A; Dilley RJ; Jones M; Simpson E; Komesaroff PA; Sudhir K
    Circulation; 2004 Feb; 109(4):537-43. PubMed ID: 14732746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of estrogenic responses with relevance to the metabolic syndrome and to menopausal symptoms in wild-type and aromatase-knockout mice.
    Bader MI; Wober J; Kretzschmar G; Zierau O; Vollmer G
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):428-34. PubMed ID: 21621614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol feeding prevents adiposity in the obese female aromatase knockout (ArKO) mouse.
    Misso ML; Hewitt KN; Boon WC; Murata Y; Jones ME; Simpson ER
    Horm Metab Res; 2005 Jan; 37(1):26-31. PubMed ID: 15702435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.